BioSpace

FDA Approves Smart Programmer for the InterStim System

“In addition to simplified programming and ongoing management of InterStim therapy, the smart programmer is discreet, which is meaningful to patients because OAB can greatly impact confidence, ...
UroToday

FDA Approves Smart Programmer for the InterStim™ System

San Francisco, CA USA (UroToday.com) -- Intuitive and Discreet Device Provides Sacral Neuromodulation Therapy for Overactive Bladder and Bowel Incontinence. Medtronic plc announced U.S. Food and Drug ...
PR TIMES

日本メドトロニック World Continence Week 2025に合わせ排尿・排便障害に ...

―2025年6月16日～6月22日World Federation of Incontinence and Pelvic Problems(WFIPP)が制定した「World Continence Week」（ワールド コンチネンス ウィーク）― 日本メドトロニック株式会社（本社：東京都港区）は、過活動膀胱および便失禁の治療を目的とした仙骨神経刺激療法 ...
BioSpace

Medtronic, Inc. Receives FDA Approval For InterStim(R) II System For Treatment Of ...

MINNEAPOLIS--(BUSINESS WIRE)--July 5, 2006--Medtronic, Inc. (NYSE:MDT - News), today announced that the U.S. Food and Drug Administration (FDA) has approved the company's InterStim® II system for the ...
MassDevice

FDA approves Medtronic’s next-gen InterStim X system

Medtronic (NYSE:MDT) announced today that the FDA approved its next-generation InterStim X recharge-free device. The medtech giant has made the latest sacral neuromodulation (SNM) therapy product from ...